Ayşegül Durak

A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats

Ayşegül Durak, Yusuf Olğar, Sinan Değirmenci et al. · Cardiovascular Diabetology · 2018 · 176 citations · Full text

Medicine, Cardiology, Pharmacology +17

Hyperglycemia-Induced Changes in ZIP7 and ZnT7 Expression Cause Zn2+ Release From the Sarco(endo)plasmic Reticulum and Mediate ER Stress in the Heart

Erkan Tuncay, Ceylan Verda Bitirim, Ayşegül Durak et al. · Diabetes · 2017 · 86 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +15

Aging related functional and structural changes in the heart and aorta: MitoTEMPO improves aged-cardiovascular performance

Yusuf Olğar, Sinan Değirmenci, Ayşegül Durak et al. · Experimental Gerontology · 2018 · 68 citations

Education, Cardiology, Physiology +14

Zn2+-transporters ZIP7 and ZnT7 play important role in progression of cardiac dysfunction via affecting sarco(endo)plasmic reticulum-mitochondria coupling in hyperglycemic cardiomyocytes

Erkan Tuncay, Ceylan Verda Bitirim, Yusuf Olğar et al. · Mitochondrion · 2018 · 54 citations

Life Sciences, Cardiology, Physiology +15

Electrophysiological basis of metabolic-syndrome-induced cardiac dysfunction

Esma N. Okatan, Ayşegül Durak, Belma Turan · Canadian Journal of Physiology and Pharmacology · 2016 · 35 citations · Full text

Life Sciences, Cardiology, Physiology +17